-Novartis buys gene therapy company, Avexis for $8.7 billion
http://investors.avexis.com/phoenix.zhtml?c=254285&p=irol-newsArticle&ID=2341482

-Spark is another gene therapy company I like, involved in hemophilia and eye-related blindness diseases
http://sparktx.com/

Follow me on twitter @matthewlepoire